234 related articles for article (PubMed ID: 24934787)
1. Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).
Shulman LN; Berry DA; Cirrincione CT; Becker HP; Perez EA; O'Regan R; Martino S; Shapiro CL; Schneider CJ; Kimmick G; Burstein HJ; Norton L; Muss H; Hudis CA; Winer EP
J Clin Oncol; 2014 Aug; 32(22):2311-7. PubMed ID: 24934787
[TBL] [
